Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

8.09
Delayed Data
As of Jun 24
 -0.32 / -3.80%
Today’s Change
7.89
Today|||52-Week Range
21.65
-45.12%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close8.41
Today’s open8.00
Day’s range7.97 - 8.18
Volume1,093,666
Average volume (3 months)187,008
Market cap$200.4M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-578.65%
Earnings growth (this year)-355.90%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-31.70%
P/E ratioNM
Price/Sales11.42
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
MDGNMedgenics Inc-0.29-5.06%
CCXIChemoCentryx Inc-0.19-4.06%
CYNACynapsus Therapeutic...-0.10-0.61%
VTLVital Therapies Inc-0.56-7.88%
Data as of 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$27.7M
Annual profit (last year)-$49.3M
Net profit margin-150.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Ann D. Rhoads
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs